Shares of BioCorRx Inc. (OTCMKTS:BICX – Get Free Report) passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.71 and traded as low as $0.32. BioCorRx shares last traded at $0.32, with a volume of 2,713 shares changing hands.
BioCorRx Stock Performance
The company has a market cap of $3.15 million, a PE ratio of -0.70 and a beta of 0.59. The business’s 50-day moving average is $0.42 and its 200 day moving average is $0.71.
BioCorRx (OTCMKTS:BICX – Get Free Report) last posted its quarterly earnings results on Tuesday, August 13th. The company reported ($0.13) EPS for the quarter.
About BioCorRx
BioCorRx Inc, through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition.
See Also
- Five stocks we like better than BioCorRx
- How to Choose Top Rated Stocks
- GE Vernova’s Rally Could Continue as Wind Business Gains Ground
- Buy P&G Now, Before It Sets A New All-Time High
- DraftKings vs. DoubleDown: Growth in the Online Gambling Boom
- How to Evaluate a Stock Before Buying
- Join UiPath’s AI Surge and Catch the Coming Stock Price Reversal
Receive News & Ratings for BioCorRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioCorRx and related companies with MarketBeat.com's FREE daily email newsletter.